Front. Oncol. Frontiers in Oncology Front. Oncol. 2234-943X Frontiers Media S.A. 10.3389/fonc.2022.1090503 Oncology Original Research Research trend of circulating tumor DNA associated with breast cancer from 2012 to 2021: A bibliometric analysis Ji Zeqi Chen Lingzhi Yang Qiuping Tian Huiting Wu Jinyao Zheng Daitian Cai Jiehui Chen Yexi * Li Zhiyang * Department of Thyroid, Breast and Hernia Surgery, General Surgery, The Second Affiliated Hospital of Shantou University Medical College, Shantou, China

Edited by: L. J. Muhammad, Federal University Kashere, Nigeria

Reviewed by: Sumayah Al-Mahmood, Al-Iraqia University, Iraq; Kun Fang, First Affiliated Hospital of Harbin Medical University, China

*Correspondence: Yexi Chen, yxchen3@stu.edu.cn; Zhiyang Li, s_zyli4@stu.edu.cn

This article was submitted to Breast Cancer, a section of the journal Frontiers in Oncology

13 01 2023 2022 12 1090503 05 11 2022 19 12 2022 Copyright © 2023 Ji, Chen, Yang, Tian, Wu, Zheng, Cai, Chen and Li 2023 Ji, Chen, Yang, Tian, Wu, Zheng, Cai, Chen and Li

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

Background

Recently, ctDNA has become the focus for scientists with respect to personalized treatment, early screening, precise diagnosis, and prognosis of BC. This paper aims to use bibliometric analysis to investigate the research status and future trends in this field.

Methods

All the related literature in the field of ctDNA and breast cancer was gathered from the Web of Science Core Collection. Data analyses were performed with R package Bibliometrics, VOS viewer 1.6.18, and online analysis in WoS. IBM SPSS (version 26.0) was used for statistical analysis.

Results

A total of 739 publications, including 472 articles and 267 reviews, were retrieved. The overall number of articles published showed an upward trend. The United States has the largest number of published articles (266 papers) and citations (20,225 times). The most productive journal was Clinical Cancer Research. Cristofanilli M was the most prolific author, while Carlos C was the most cited one. The most frequent keywords excluding the search subject were “liquid biopsy”, “plasma”, “mutations”, “metastatic breast cancer”, “acquired resistance”.

Conclusion

This article explored the application value of ctDNA in breast cancer with bibliometric analysis, offering an overall and intuitive understanding of this topic and revealing the study trends in the past ten years.

circulating tumor DNA breast cancer bibliometric analysis VOSviewer Bibliometrics

香京julia种子在线播放

    1. <form id=HxFbUHhlv><nobr id=HxFbUHhlv></nobr></form>
      <address id=HxFbUHhlv><nobr id=HxFbUHhlv><nobr id=HxFbUHhlv></nobr></nobr></address>

      Introduction

      Breast cancer (BC) has been proven to be the most common malignancy with the highest mortality rate in women worldwide (1). Besides, BC is heterogeneous on the molecular level which was categorized into four subtypes according to different molecular features (2). And its therapeutic strategies vary according to the molecular subtypes. It is necessary to continuously assess the disease status and alternations of tumor biology (2). In this context, relying on serial biopsies is impractical, leading to a call for liquid biopsies which had the advantage on reflecting tumor heterogeneity (3). On this account, many scholars have been devoted to finding appropriate biomarkers for the diagnosis, treatment efficacy, prognosis, recurrence, and metastasis of BC.

      Circulating tumor DNA (ctDNA) is a cancer-derived blood biomarker and also the widely studied circulating biomarker applied to liquid biopsy till now (4). With the development of the cancer genome project (CGP) and the wide application of next-generation sequencing (NGS), which effectively increase the sensitivity and specificity of ctDNA screening (5, 6), more and more researchers suggest ctDNA analysis as a promising biomarker for diagnosis, prognosis, and treatment of some malignancies (7, 8), such as lung cancer, colorectal cancer (CRC), BC, hepatocellular carcinoma (HCC) (911). Because of its capability to assess tumoral heterogeneity, ctDNA has become the focus for scientists with respect to personalized treatment, early screening, precise diagnosis, and prognosis of BC (12). O’Leary B, et al. have reported that the dynamic of ctDNA can be used to predict the long-term outcome of CDK4/6 inhibitors therapy in BC (13). However, there were still bottlenecks in the clinical application, for example, the blood collection, storage, and detecting techniques (14). What’s more, as time goes by, the somatic mutation related to cancer in the plasma may not be specific in people with cancer (8).

      Bibliometrics is defined as the quantitative assessment of scientific outputs within a particular field using statistical methods (15, 16). Benefiting from the bibliometric analysis, scholars can collect information from retrieved academic literature, discuss their distribution characteristics and collaboration among authors and affiliations, evaluate the scientific quality and have a better understanding of emerging research topics and developments (1517).

      Although related articles in this field were widely discussed by researchers, there has been no bibliometric analysis found to comprehensively investigate the current progress, hotspots, and challenges with respect to ctDNA and BC. Based on this situation, this paper aims to use scientometric analysis to figure out the publications, authors, countries, journals, and cited references in the field of ctDNA and BC in the last decade, summarizing the hotpots and novel trends in this domain and providing references for future research direction.

      Materials and methods Data collection

      Subject words were searched using the Medical Subject Headings (Mesh) database of Pubmed (https://pubmed.ncbi.nlm.nih.gov/) to make the retrieval more comprehensive and accurate. All the related literature about the relationship between ctDNA and breast cancer was gathered from Web of Science (WoS) Core Collection database with no limitation for citation index, including Science Citation Index Expanded (SCI-EXPANDED), Social Sciences Citation Index (SSCI), Arts & Humanities Citation Index (ESCI), Current Chemical Reactions (CCR-EXPANDED), Index Chemicus (IC). The query parameter was designed as followed: #1, TS=(“breast neoplasm*”) OR TS=(“breast tumor*”) OR TS=(“breast cancer*”) OR TS=(“mammary cancer*”) OR TS=(“mammary neoplasm*”) OR TS=(“breast carcinoma*”) OR TS=(“mammary carcinoma*”); #2, TS=(“Circulating Tumor DNA”) OR TS=(“Cell-Free Tumor DNA”) OR TS=(“ctDNA”); #3, “#1”, and “#2”. A total of 1097 pieces of literature were got in the preliminary search. And then, we did some screening: the publication year was refined from January 1st, 2012 to December 31st, 2021, the document type was set to articles or reviews, and the language was restricted to English. And we also excluded the articles published in 2022. All the searches were performed on August 28, 2022 and finally, we got 739 publications, including 472 articles and 267 reviews, accounting for 63.870% and 36.130%, respectively. The flow diagram of data collection and filtering was shown in Figure 1 .

      Flowchart of data collection and analysis.

      Data analysis

      With the function of “analyze results” in WoS, we did the preliminary analysis of the retrieved literature, including author, publication year, document type, research direction, country, affiliated institution, publisher. The function of “citation report” was used to acquire the information about the number and citation frequency of each paper.

      Then, the information of the literature retrieved by WoS was exported in plain txt format and imported into the tools of biblioshiny (the shiny app for bibliometrix) and VOSviewer for further analysis of annual production, authors, countries, journals, institutions, keywords, and citations.

      Bibliometrix package is a scientometric analysis software based on R language. In this study, we used the biblioshiny website with R language (version R 4.1.0) to analyze the bibliographic information of retrieved literature. An overview of basic information contained the time span, annual growth rate, average citations per doc, document contents, document types etc. Descriptive analysis and visual presentation about the annual production, average citation per year, contribution of countries, organizations, and journals, authors publications and impact were acquired. The author impact was evaluated by Hirsch h-index, g-index, m-index. The h-index indicated the impact of a researcher’s scientific outputs, defined as the largest number of articles published by a researcher which have been cited at least h times (18, 19).

      VOSviewer (version 1.6.18), a computer program for constructing and visualizing bibliometric maps in an intuitive and intelligible view (20). In this study, VOSviewer was applied to perform the co-authorships analysis of countries, organizations, and authors, bibliographic coupling analysis of journals, co-citation analysis of cited reference, co-occurrence analysis of keywords. We also used this software to gain the total link strength among different countries, organizations, and authors.

      IBM SPSS (version 26.0) was used for statistics analysis. We set the data type as numerical variables and used Spearman correlation analysis to analyze the correlations between selected variables. All the tests were two-sided, and p-values < 0.05 were considered statistically significant.

      Results Analysis of annual publication trends and average citations

      A total number of 739 documents contributing to this research field from 2012 to 2021 was obtained from WoS. Figure 2A showed the change in annual publication volume from 2012 to 2021 (r2 = 0.973, [CI, 0.806 to 1.000]; p < 0.001). From 8 articles published in 2012 to 130 articles published in 2021, the overall number of articles published showed an upward trend, with an average annual growth rate of 36.31%. The highest number of publications was produced in 2020 (131, 17.72%). From 2012 to 2014, there were few articles in this field, with a total of 31 articles published in the three years, reflecting that this field arouse little concern from the researchers at that time. From 2015 to 2018, the annual output increased rapidly, with a median annual output growth rate of 34.65% (2015 had the highest output growth rate of 65.11%), indicating a sharp rise in academic attention and study in this field during this period. There was a small decline in publishing in 2019 but it remained high. From 2019 to 2021, the number of publications continued to increase slowly, indicating that researchers or scholars have kept a watchful eye on this field.

      Annual publication and average article citations per year of ctDNA in the field of breast cancer from 2012 to 2021. (A) Annual publication from 2012 to 2021 in this field; (B) Average article citations per year from 2012 to 2021 in this field.

      Among all the retrieved articles, a total of 37,987 citations were received and the average citation frequency of each article was 51.4 times. Figure 2B showed the average citations per year from 2012 to 2021. The number of citations increased sharply in 2014, reaching the highest peak (n=47.68) in the past decade. In 2018. the citations per article reached another small peak (n=14.1) and then it continued to decline until it reached the lowest average citation frequency in 2021 (n=6.47).

      Analysis of country and organizations

      Country analysis helps to reveal the geographical distribution of relevant papers in the field. There are 52 countries involved in the 739 retrieved documents contributing to this research area. The top 10 cited countries according to the rank of total citations were performed in Table 1 . We can learn that United States (US) has the largest number of published articles (266 papers), accounting for 35.99%; and then China (148 papers, 20.02%) followed by Italy (86 papers, 11.63%) and the United Kingdom (UK) (73 papers, 9.87%). The number of citations of a country’s published literature is also an important factor to measure its influence on the field. US is still the top cited country with 20,225 times, followed by UK (8,377 citations), Italy (7,913 citations). Australia (7,338 citations), Germany (6,856 citations). However, in terms of total citations per production, Sweden (436 citations), Australia (236.7 citations), and Brazil (192.1 citations) took the top 3 countries, respectively. Obviously, the influence of US on this field is beyond doubt. Moreover, it is worth noting that although the publications of Italy, UK and Australia is less than 100, their publications are cited more frequently than those of China.

      Top 10 cited countries contributing to this research area.

      Country Production %/of papers Total citations TC/P
      USA 266 35.994 20225 76.033
      UK 73 9.878 8377 114.753
      Italy 86 11.637 7913 92.012
      Australia 31 4.194 7338 236.710
      Germany 59 7.984 6856 116.203
      France 57 7.713 4448 78.035
      China 148 20.027 3387 22.885
      South Korea 20 2.706 3338 166.9
      Sweden 7 0.947 3052 436
      Brazil 15 2.030 2882 192.133

      TC, the total number of citations a country has received.

      TC/P, the average number of citations per production in a country.

      And then VOSviewer was used to conduct co-authorships analysis of countries with the threshold set as 3 documents. The size of nodes represents the quantity of literature published in each country, and the larger the node is, the more the country produced. The connection between nodes represents the cooperation between countries, and the thicker the line, the closer the cooperation between countries. It is apparent that the United States was the central country in this field, and has a close cooperation with China, Italy, UK, France, and Germany ( Figure 3 ). The total intensity of links of USA (212) is significantly higher than other countries. In addition, although China had a higher academic output, the total link intensity (69) was less than Italy (129) and UK (124).

      Co-authorships analysis of countries in network visualization map.

      Setting a threshold of 5 documents of an organization in the co-authorships analysis of organizations, and we got 91 of 1375. Figure 4 provides a network visualization map of the major organizations; Among them, the top 5 for publications were University of Texas MD Anderson Cancer Center (n=28), Harvard Medical School (n=26), Institute of Cancer Research (n=23), Memorial Sloan-Kettering Cancer Center (n=22) and Royal Marsden Hospital (n=21). However, the top 3 with most citations were Memorial Sloan-Kettering Cancer Center (6219 citations), University of Turin (4259 citations), and University of Cambridge (4085 citations). The top three in total link strength were Institute of Cancer Research (43), Royal Marsden Hospital (43), and Memorial Sloan-Kettering Cancer Center (39) ( Table 2 ). Notably, of the top 10 most productive organizations, five are from the United States, three are from the United Kingdom, and the other two are from Italy and Belgium.

      Co-authorships analysis of organizations in network visualization map.

      Top 10 organizations based on publications.

      Organization Publication Total citations Total link strength Country
      University of Texas MD Anderson Cancer Center 28 3093 68 USA
      Harvard Medical School 26 1382 55 USA
      Institute of Cancer Research 23 2695 68 UK
      Memorial Sloan Kettering Cancer Center 22 6219 67 USA
      Royal Marsden Hospital 21 2608 65 UK
      IRCCS 18 636 29 Italy
      Northwestern University 18 539 37 USA
      Cambridge University 17 4085 42 UK
      Dana-Farber Cancer Institute 15 1710 44 USA
      Vrije Universiteit Brussel 15 957 30 Belgium
      Analysis of journal and research categories

      The analysis of journals in related research fields can provide references for researchers to get better submission selection. There are 300 journals active in the field; By setting 5 as the minimum number of documents of a source, 35 of them meet the thresholds and the visualization of sources analysis was got ( Figure 5A ). Clinical Cancer Research got the largest number of publications (n=32), followed by Cancers (n=29), the third to fifth were Oncotarget (n=24), Breast Cancer Research and Treatment (n=17), and Frontiers in Oncology (n=17). The total number of articles published in the top 10 journals was 179, accounting for 24.22%. Science Translational Medicine had the most citations (5205 citations) with only 9 documents. And the next were Clinical Cancer Research (2489 citations), Journal of Clinical Oncology (2138 citations), Cancer Discovery (1761 citations) and Annals of Oncology (1297 citations). The h-index is an indicator reflecting the quality of scientific publications (21). In this study, Clinical Cancer Research ranked first with the h-index of 24, and followed by Oncotarget and Annals of Oncology, with the same h-index of 16, and Molecular Oncology (h-index = 11). Of the top 10 journals based on publications, Clinical Cancer Research was the first to start publishing articles in this field in 2012 and 70% of them started publishing in 2014-2015. ( Supplementary Table S1 ).

      Bibliographic coupling analysis of sources in this fields. (A) Bibliographic coupling analysis of journals in network visualization map. (B) Bibliographic coupling analysis of journals in overlay visualization map.

      From the overlay visualization map of sources analysis in VOSviewer ( Figure 5B ), as the blue color represent the earlier average publication year while the yellow color represents the more recent average publication year, we found that Science Translational Medicine, Cancer Research, and Oncotarget have been active in this field at least 5 years ago. Moreover, although Cancers, and Frontiers in Oncology have become active in the past 2 years, the number of published articles has already ranked among the top 5.

      There are 46 research categories and 70 publishers involved in the retrieved literature. The top 5 subject categories and publishers based on the number of publications are listed in Supplementary Table S2 . The most represented one is “Oncology” (n=429, 58.051%), accounting for more than half of all documents. Followed by “Research Experimental Medicine” (n=65, 8.796%) and “Cell Biology” (n=60, 8.119%). Regarding publishers, “Springer Nature” ranked the first (n=155, 20.974%), followed by “Elsevier” (n=113, 15.291%), “Amer Assoc Cancer Research” (n=57, 7.713%), and “Mdpi” (n=51, 6.901%).

      Analysis of authors

      Through statistical analysis, 5017 authors contributed to all the 739 documents, 15 among them were single-authored documents. The average number of authors per document was 6.78, and the average number of co-authors per document was 9.56. Cristofanilli M from US was the most prolific author (19 articles), followed by Turner NC, from UK (n=17) and Ma F, from US (n=16) ( Table 3 ). Ranked by h-index, Turner NC was the top 1 (h-index = 15), and then Garcia-murillas I (h-index = 13), Hhrebien S (h-index = 12), Cristofanilli M (h-index = 11). M-index is an indicator for “scientific quality” which was corrected for the time of scientific activity (21). Turner NC and Garcia-murillas I also occupied the top two places, with the m-index of 1.875 and 1.675, respectively. Cristofanilli M ranked No.3 (m-index = 1.571) and followed by Hrebien S (m-index = 1.500). In terms of the most cited authors in this fields, the results were a little different. Carlos C ranked first, with 7 published papers receiving 3723 citations, indicating that his literature has made a significant contribution to the development of the field. And it was followed by Nitzan R (3520 citations), and Sarah-Jane D (2405 citations), with publication count less than 10 articles, suggesting a great impact of each of their literature on this field.

      The top 10 with most published authors in this field.

      Highly published Authors NP TC h-index g-index m-index
      CRISTOFANILLI M 18 999 11 18 1.571
      TURNER NC 17 2491 15 17 1.875
      MA F 16 306 9 16 1.286
      BIDARD FC 15 870 10 15 1
      GUAN YF 15 282 9 15 1.286
      PIERGA JY 15 541 9 15 1
      GARCIA-MURILLAS I 14 1715 13 14 1.625
      XU BH 14 284 8 14 1.143
      YI ZB 14 298 9 14 1.286
      YI X 13 333 9 13 1.286

      NP: number of publications.

      TC: total cications.

      Co-authorship analysis between authors was conducted using VOSviewer, and 79 co-authors wrote more than 5 articles. Preserving the largest set of 67 connected items and we got the Visualization Map ( Figure 6 ). Cristofanilli M had the most total link strength (100), and was followed by Ma F (99), Yi ZB (96), Xu BH (90), Guan XW (81). The co-citation analysis of cited authors is shown in Supplementary Figure S1 , where a total of 15 authors were cited more than 150 times. The top five cited authors are Dawson SJ (321), Diehl F (302), Bettegowda, C (275), Garcia-Murillas I (271), and Mmurtaza M (243).

      Co-authorship analysis between authors in network visualization.

      Analysis of citations

      We used bibliometrix to analyze the specific information of the top 10 documents in this field ( Supplementary Table S3 ). All these articles were all published between 2012 and 2018. 70% of them published before 2015. Among them, the most cited paper was “Detection of circulating tumor DNA in early- and late-stage human malignancies (Bettegowda, C 2014)” published in Science Translation Medicine Right, with the total citations 2655, analyzing the early detection of DNA in human malignancies (22). Dawson et al. published an article in The New England Journal of Medicine in 2013 titled “Analysis of Contaminated Tumor DNA to Monitor Breast Cancer”, with the second highest citations (1,488). In this article, it revealed that contaminated tumor DNA is a highly sensitive and informative biomarker of breast cancer (23). The third is “Liquid Biopsies: Genotyping Circulating Tumor DNA” published by Diaz, LA and Bardelli, A in the Journal of Clinical Oncology in 2014, receiving 1374 direct citations. This paper describes the sensitivity and accuracy of ctDNA based liquid biopsy to type the mutated genes of tumor cells, which is of great significance for clinical research (24). From the perspective of content, these three papers are related to the theoretical basis of ctDNA as a monitoring index for the detection of early breast cancer, which are representative and influential basic papers in this field and have far-reaching influence and significance for subsequent research.

      From the co-citations analysis of cited references in VOSviewer, we can learn that 215 of the 24894 co-cited references had been cited at a minimum number of 20 times. In the network visualization, all the cited references are divided into four clusters and larger node represents more reference cited ( Figure 7A ). The top cluster with 96 items is shown in red, indicating the most interesting research area. The redder color means more citations in the density view ( Figure 7B ). Supplementary Table S4 listed the top ten most co-cited references. The top five cited references are Dawson SJ (2013; 310 citations), Bettegowda C (2014; 266 citations), Garcia-murillas I (2015; 228 citations), Diehl F (2008; 189 citations), Murtaza M (2013; 173 citations).

      Co-citations analysis of cited references in this research fields. (A) The network visualization of co-citations analysis of cited references. (B) The density visualization of co-citations analysis of cited references.

      Analysis of keywords

      291 keywords were obtained to perform keyword analysis by setting the occurrence frequency to more than 5. With the function of clustering on VOSviewer, all keywords were divided into four clusters shown in different colors ( Supplementary Figure S2A ). The size of an item’s circle and label is proportional to its importance. The items in the same cluster with the same color mean higher correlation with each other (20). The red cluster and the green cluster are the two main clusters in this field. The red cluster contains 117 keywords, mainly including circulating tumor DNA, breast cancer, mutations, therapy, heterogeneity and so on. The green cluster contains 108 keywords, including cell-free DNA, plasma, acquired resistance, and so on. The blue cluster is the third largest cluster with 65 items, including liquid biopsy, survival, metastatic breast cancer (MBC), circulating tumor cell and so on. In the density visualization map, the color of an item depends on its frequency of occurrence, which is easy for us to pay attention to the most important areas in a map (20). The redder color means the heavier weight. As shown in Supplementary Figure S2B , the most frequent keywords excluding the search subjects were “liquid biopsy” (n=196), “plasma” (n=112), “mutations” (n=101), “metastatic breast cancer” (n=100), “acquired-resistance” (n=98) and so on. What’s more, the overlay visualization map showed the average publication year in which keywords appears in these publications ( Supplementary Figure S2C ). Yellow means the later it occurred in the articles. We can learn that the focus of research areas ranged from the expression of ctDNA genes in various cancers to the value of peripheral blood ctDNA as a biomarker and then to the diagnostic and prognostic value of ctDNA in BC.

      The word or phrases that frequently appear in the title of an article’s cited reference were extracted and defined as keywords plus, which is used to identify research topics more descriptively and objectively (25). From the co-occurrence analysis of keywords plus analysis in VOSviewer ( Supplementary Figure S3A ), except from the search subjects, the top 5 with most cited keywords were “cell-free DNA” (n=140), “plasma” (n=105), “metastatic breast cancer” (n=100), “acquired-resistance” (n=98), and “mutations” (n=98). The overlay visualization map of keywords plus analysis showed the most recent keywords, including “liquid biopsy”, “cell-free DNA”, “ESR1 mutations”, “survival”, “resistance”, “double-blind”, “palbociclib”, and “fulvestrant”. ( Supplementary Figure S3B ).

      Discussion

      It remains a global challenge for cancers to the early diagnosis and effective recurrence detection and therapeutic evaluation in spite of the progress made in the treatment (26). In this case, a calling for a specific and effective biomarker has arisen, thus achieving the detection of breast cancer at an early and treatable stage (27).

      The research scope of this paper is set from 2012 to 2021. In 2012, only 8 articles were published in the research field of ctDNA and BC. Since 2015, the number of articles published in this field has grown rapidly, reaching 103 articles in 2017, exceeding 100 articles every year since then, and reaching a peak of 131 articles in 2021. It showed a burst of interest and sustained attention on this field. As of the retrieval date, the papers analyzed in this study have been cited for 37,987 times, with an average of 51.4 times for each paper. Since 2012, the number of citations has increased 258 times, and the literature published in 2014 has the highest number of citations per paper, reflecting the increasing attention and importance of this field. What’s more, it is indicated that the articles published in 2014 have laid an important foundation for the development of this field. Among the top 10 most cited documents, 90% verified that ctDNA has important clinical significance for the identification of early cancer (2224, 2833), and mainly discussed the significance of ctDNA for the diagnosis, prognosis prediction and management of systemic therapy of cancer. From the perspective of content, the top 3 most cited papers are related to the theoretical basis of ctDNA as a monitoring index for the detection of early breast cancer, which are representative and influential basic papers in this field and have far-reaching influence and significance for subsequent research. Two of these papers demonstrated that ctDNA could be used to identify and monitor MBC and identify breast cancers at high risk of recurrence (23, 30). Interestingly, the review of ctDNA published by Merker et al. concluded that there is insufficient evidence to demonstrate the clinical efficacy and utility of ctDNA in cancer screening, treatment monitoring or residual disease monitoring, and advanced cancer (34). This may be related to the fact that the latter authors put more emphasis on the feasibility of practical clinical application.

      In total, 52 countries contributed to the field. The United States is undoubtedly the dominant country in this field, with the largest total number of publications, total number of citations and total link strength. Further analysis displayed that although the number of articles published in the UK and Italy was less than that in China, the number of citations and the total link strength of their articles were significantly higher than that of China, indicating that the academic influence of a country is not only reflected in the number of articles published, but also needs to be comprehensively evaluated by the number of citations, cooperation with other countries and link strength. China should encourage innovative inventions and research, not just the quantity of published literature.

      On the top10 for publications of 300 journals, Clinical Cancer Research or Oncotarget was the first choice for many researchers to submit articles five years ago. In the past two years, Cancers and Frontiers in oncology have become the focus of submission for scholars, with a sharply rising number of publications. Meanwhile, in the past three years, breast cancer related journals such as Breast Cancer Research and Treatment, NPJ Breast cancer and Breast Cancer Research have also achieved a satisfactory volume of scientific publications in this field. It can be speculated that the relationship between ctDNA and BC is becoming more and more popular among these special journals related to breast cancers.

      Cristofanilli M (n=19), Turner NC (n=17), Ma F (n=16), Bidard FC (n=15), Guan YF (n=15) were top five authors by number of publications. Besides, Turner NC had the highest h-index. His first paper on this subject was published in 2015, which demonstrated that targeted sequencing of ctDNA can be used to detect minimal residual disease in BC and thus more accurately predict genetic events of metastatic recurrence (30). It will be helpful for guiding adjuvant therapeutic intervention of early breast patients at high risk of metastasis and recurrence. The author with the highest numbers of citations is Carlos C. His first paper on this subject, published in 2012, showed that tagged-amplicon deep sequencing (Tam-Seq) was a feasible method for noninvasive detection of both abundant and rare mutations of ctDNA, which lays a foundation for personalized genomics for “liquid biopsy” (31). In 2013, Carlos C further proved that ctDNA show sensitivity and specificity in the detection of MBC (23). Interestingly, we notice that it is divided into six items in the co-authorship analysis between authors, the links within items are strong while the links between items are sparse.

      Keyword analysis can be used to present emerging topics and predict future research directions in this field. From the perspective of keyword analysis, the research field of ctDNA and BC is mainly divided into three parts. At the early stage, the development of ctDNA to detect and monitor tumor burden has been widely discussed and it is indicated that ctDNA is feasible to be used to detect tumor dynamics in some solid cancer patients (22), such as MBC (23), pancreatic cancer (35), CRC (36). Furthermore, sequencing technologies of ctDNA to monitor cancer mutations are constantly evolving. Tim F. et al. have developed a method for Tam-Seq and used it to identify cancer mutations in ctDNA, with sensitivity and specificity of > 97% (31). With more detailed studies have been carried out, researchers are concerned about the clinical implications of gene mutations in ctDNA for cancer evolution and treatment modification. David C. et al. have verified that a high frequency of estrogen receptor alpha gene (ESR1) mutations occurred in ctDNA from patients with MBC by NGS (37). On this basis, further study was conducted to explore the significance of detecting ESR1 mutations in guiding personalized treatment decisions for MBC (38). Some researchers have focused on tumor heterogeneity and suggested that ctDNA can be used to predict treatment outcome by assessing tumor heterogeneity (39). Recently, the main attention of the field has been shifted to evaluate the sensitivity and specificity of liquid biopsy in a large clinically relevant cohort. Studies have showed that ctDNA was identified as a promising biomarker for real-time efficacy evaluation of BC, recurrence risk stratification, and personalized follow-up (40). Nonetheless, subsequent clinical trials are still needed to verify the clinical feasibility of performing liquid ctDNA biopsies on a large scale. From the keywords plus analysis, we can infer the emerging themes like “liquid biopsy”, “cell-free DNA”, “ESR1 mutations”, “survival”, “resistance”, “double-blind”, “palbociclib”, and “fulvestrant”, is cited until 2019, which may become hot topics in the future and needs further research.

      “cell-free DNA” (cfDNA) is thought to be secreted through apoptosis and necrosis, and the kirsten rat sarcoma viral oncogene (KRAS) mutations detected in cfDNA were found of tumor origin, giving rise to the term ‘ctDNA’ (29). In the past few years, “liquid biopsy” has been used to isolate cancer derivatives circulating in blood or other body fluids, longitudinally detect cancer progression and residual disease after treatment, and predict disease recurrence at an early stage (41). In addition, the development of high-sensitivity techniques provided important information for the diagnosis, disease progression and treatment response of BC (42). However, limitations remain since ctDNA represents a small fraction of total cfDNA and is not shed by all tumors, giving challenges in the reliability and reproducibility of detecting low-mutation allele mutations (41, 43). What is more, the acquisition and analysis of ctDNA samples was not standardized and some scholars proposed to develop multi-parameter assays and combine different analytes to improve the prognosis of malignant tumors (44). Whereas, there is still insufficient of clinical trials to prove the efficacy of liquid biopsy (41). Therefore, further clinical trials are needed to improve its accuracy and sensitivity, which may be an interesting topic for continued discussion in the future.

      The keywords of “ESR1 mutations”, “survival” and “resistance” are closely related to each other. “ESR1 mutations” are common in patients with ER-positive MBC during aromatase inhibitors (AI) medications, especially after the development of hormone resistance (45). Early identification of ESR1 mutations in ctDNA can predict the disease evolution of patients with MBC, manage clinical treatments (46). Lauren D et al. have evaluated ctDNA dynamics as promising biomarker for medicine efficacy and prognostic prediction for progress-free survival in MBC (47). In addition, ctDNA analysis was also conducted to identify potential resistance mechanisms to CDK4/6 inhibitors in estrogen receptor positive BC (48). Further confirmation of the clinical effectiveness of ctDNA analysis are required. Given advanced cancer assessment provided by ctDNA testing, related research on neoadjuvant chemotherapy for early-stage high-risk breast cancer and survival analysis for advanced MBC has been carried out recently, which further verify facilitation of the prediction of pathological complete response (pCR) and the risk of metastatic recurrence, as well as real-time assessment of treatment response (4951). Circulating DNA was detected for molecular analysis to evaluate the prognostic value in a multicenter, “double-blind”, phase 3 randomized controlled trial (PALOMA-3), which confirmed the significant improvement of “fulvestrant” plus “palbociclib” in overall survival and progress-free survival compare with fulvestrant plus placebo (52, 53). It may also trigger more clinical trials on survival analysis of different medication treatments in advanced, metastatic breast cancer in the future.

      There were still limitations in the present study. Firstly, we only used the web of science database to search for related publications, which may exclude some influential papers included from other databases, such as PubMed, Embase, and Scopus, resulting in selection bias. However, WoS is still the most extensively used tool for bibliometric analysis, with rich information of distribution of authors, countries, journals, organizations, and citations. Secondly, the research criterion of language type was limited to English. It is possible to cause a lack of high-impact articles written in other language. Thirdly, the articles published this year have not been bring into study, the result of this research is only applicable to the time point until August 28, 2022. Despite these, we believe that our finding can provide valuable advice on future development for researchers in this field.

      Conclusions

      In this study, we explored the application value of ctDNA in breast cancer with bibliometric analysis, offering an overall and intuitive understanding of this topic and revealing the study trends in the past ten years. Publications related to this field showed a rapidly upward trend. The keyword analysis indicated that the current focus of this field may be the detection of genetic mutation in ctDNA to predict disease progression and treatment effectiveness of BC. Further clinical trials of ctDNA and the standardization and clinical feasibility of liquid biopsy detection are future attention.

      Data availability statement

      The original contributions presented in the study are included in the article/ Supplementary Material . Further inquiries can be directed to the corresponding authors.

      Author contributions

      JC, ZL, and YC participated in the conception and design of the study. QY and HT collected the data. JC and LC provided the guiding suggestions on application usage and data analysis. ZJ, JW, and DZ were involved in data analysis and drafted the manuscript. ZJ was the major contributor to writing the article. LC revised the final version of the manuscript. All authors contributed to the article and approved the submitted version.

      Funding

      This work was supported by the Special Fund Project of Guangdong Science and Technology (210728156901524, 210728156901519), Medical Scientific Research Foundation of Guangdong Province, China (grant number A2021432), Shantou Medical Science and Technology Planning Project (grant number 210521236491457, 210625106490696, 220518116490772, 220518116490933).

      Acknowledgments

      The authors thank those individuals who provided software usage guidance, language help, writing assistance, and proofreading of the article.

      Conflict of interest

      The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

      Publisher’s note

      All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

      Supplementary material

      The Supplementary Material for this article can be found online at: /articles/10.3389/fonc.2022.1090503/full#supplementary-material

      References Bray F Ferlay J Soerjomataram I Siegel RL Torre LA Jemal A . Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Cancer J Clin (2018) 68(6):394424. doi: 10.3322/caac.21492 Harbeck N Penault-Llorca F Cortes J Gnant M Houssami N Poortmans P . Breast cancer. Nat Rev Dis Primers (2019) 5(1):66. doi: 10.1038/s41572-019-0111-2 Gingras I Salgado R Ignatiadis M . Liquid biopsy: will it be the 'magic tool' for monitoring response of solid tumors to anticancer therapies? Curr Opin Oncol (2015) 27(6):560–7. doi: 10.1097/cco.0000000000000223 Bortolini Silveira A Bidard F-C Tanguy M-L Girard E Trédan O Dubot C . Multimodal liquid biopsy for early monitoring and outcome prediction of chemotherapy in metastatic breast cancer. NPJ Breast Cancer (2021) 7(1):115. doi: 10.1038/s41523-021-00319-4 Newman AM Bratman SV To J Wynne JF Eclov NC Modlin LA . An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage. Nat Med (2014) 20(5):548–54. doi: 10.1038/nm.3519 Diehl F Schmidt K Choti MA Romans K Goodman S Li M . Circulating mutant DNA to assess tumor dynamics. Nat Med (2008) 14(9):985–90. doi: 10.1038/nm.1789 Cheng FF Su L Qian C . Circulating tumor DNA: A promising biomarker in the liquid biopsy of cancer. Oncotarget (2016) 7(30):48832–41. doi: 10.18632/oncotarget.9453 Pessoa LS Heringer M Ferrer VP . ctDNA as a cancer biomarker: A broad overview. Crit Rev Oncol Hematol (2020) 155:103–9. doi: 10.1016/j.critrevonc.2020.103109 Douillard JY Ostoros G Cobo M Ciuleanu T McCormack R Webster A . First-line gefitinib in Caucasian EGFR mutation-positive NSCLC patients: a phase-IV, open-label, single-arm study. Br J Cancer (2014) 110(1):5562. doi: 10.1038/bjc.2013.721 Hench IB Hench J Tolnay M . Liquid biopsy in clinical management of breast, lung, and colorectal cancer. Front Med (2018) 5:9. doi: 10.3389/fmed.2018.00009 Jiang P Chan CWM Chan KCA Cheng SH Wong J Wong VW-S . Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients. Proc Natl Acad Sci (2015) 112(11):E1317–E25. doi: 10.1073/pnas.1500076112 Freitas AJA Causin RL Varuzza MB Calfa S Hidalgo Filho CMT Komoto TT . Liquid biopsy as a tool for the diagnosis, treatment, and monitoring of breast cancer. Int J Mol Sci (2022) 23(17):9952. doi: 10.3390/ijms23179952 O'Leary B Hrebien S Morden JP Beaney M Fribbens C Huang X . Early circulating tumor DNA dynamics and clonal selection with palbociclib and fulvestrant for breast cancer. Nat Commun (2018) 9(1):896. doi: 10.1038/s41467-018-03215-x Rolfo C Cardona AF Cristofanilli M Paz-Ares L Diaz Mochon JJ Duran I . Challenges and opportunities of cfDNA analysis implementation in clinical practice: Perspective of the international society of liquid biopsy (ISLB). Crit Rev oncology/hematol (2020) 151:102978. doi: 10.1016/j.critrevonc.2020.102978 Chen X Ding R Xu K Wang S Hao T Zhou Y . A bibliometric review of natural language processing empowered mobile computing. Wireless Commun Mobile Computing (2018) 2018:1827074. doi: 10.1155/2018/1827074 Chen X Xie H Wang FL Liu Z Xu J Hao T . A bibliometric analysis of natural language processing in medical research. BMC Med Inf decision making (2018) 18(Suppl 1):14. doi: 10.1186/s12911-018-0594-x Chen X Chen B Zhang C Hao T . Discovering the recent research in natural language processing field based on a statistical approach. emerging technologies for education;. Cham: Springer International Publishing (2017). Cobo MJ López-Herrera AG Herrera-Viedma E Herrera F . An approach for detecting, quantifying, and visualizing the evolution of a research field: A practical application to the fuzzy sets theory field. J Informetrics (2011) 5(1):146–66. doi: 10.1016/j.joi.2010.10.002 Hirsch JE . An index to quantify an individual's scientific research output. Proc Natl Acad Sci (2005) 102(46):16569–72. doi: 10.1073/pnas.0507655102 van Eck NJ Waltman L . Software survey: VOSviewer, a computer program for bibliometric mapping. Scientometrics (2010) 84(2):523–38. doi: 10.1007/s11192-009-0146-3 von Bohlen Und Halbach O . How to judge a book by its cover? How useful are bibliometric indices for the evaluation of "scientific quality" or "scientific productivity"? Ann Anat = Anatomischer Anzeiger Off Organ Anatomische Gesellschaft (2011) 193(3):191–6. doi: 10.1016/j.aanat.2011.03.011 Bettegowda C Sausen M Leary RJ Kinde I Wang YX Agrawal N . Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci Trans Med (2014) 6(224):224ra24. doi: 10.1126/scitranslmed.3007094 Dawson SJ Tsui DWY Murtaza M Biggs H Rueda OM Chin SF . Analysis of circulating tumor DNA to monitor metastatic breast cancer. New Engl J Med (2013) 368(13):1199–209. doi: 10.1056/NEJMoa1213261 Diaz LA Bardelli A . Liquid biopsies: Genotyping circulating tumor DNA. J Clin Oncol (2014) 32(6):579. doi: 10.1200/jco.2012.45.2011 Aria M Alterisio A Scandurra A Pinelli C D'Aniello B . The scholar's best friend: research trends in dog cognitive and behavioral studies. Anim Cogn (2021) 24(3):541–53. doi: 10.1007/s10071-020-01448-2 Maeda H Khatami M . Analyses of repeated failures in cancer therapy for solid tumors: poor tumor-selective drug delivery, low therapeutic efficacy and unsustainable costs. Clin Trans Med (2018) 7(1):e11. doi: 10.1186/s40169-018-0185-6 Jabbari N Akbariazar E Feqhhi M Rahbarghazi R Rezaie J . Breast cancer-derived exosomes: Tumor progression and therapeutic agents. J Cell Physiol (2020) 235(10):6345–56. doi: 10.1002/jcp.29668 Cohen JD Li L Wang YX Thoburn C Afsari B Danilova L . Detection and localization of surgically resectable cancers with a multi-analyte blood test. Science (2018) 359(6378):926. doi: 10.1126/science.aar3247 Wan JCM Massie C Garcia-Corbacho J Mouliere F Brenton JD Caldas C . Liquid biopsies come of age: towards implementation of circulating tumour DNA. Nat Rev Cancer (2017) 17(4):223–38. doi: 10.1038/nrc.2017.7 Garcia-Murillas I Schiavon G Weigelt B Ng C Hrebien S Cutts RJ . Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer. Sci Trans Med (2015) 7(302):302ra133. doi: 10.1126/scitranslmed.aab0021 Forshew T Murtaza M Parkinson C Gale D Tsui DWY Kaper F . Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA. Sci Trans Med (2012) 4(136):136ra68. doi: 10.1126/scitranslmed.3003726 Alix-Panabieres C Pantel K . Clinical applications of circulating tumor cells and circulating tumor DNA as liquid biopsy. Cancer Discovery (2016) 6(5):479–91. doi: 10.1158/2159-8290.Cd-15-1483 Heitzer E Ulz P Geigl JB . Circulating tumor DNA as a liquid biopsy for cancer. Clin Chem (2015) 61(1):112–23. doi: 10.1373/clinchem.2014.222679 Merker JD Oxnard GR Compton C Diehn M Hurley P Lazar AJ . Circulating tumor DNA analysis in patients with cancer American society of clinical oncology and college of American pathologists joint review. Arch Pathol Lab Med (2018) 142(10):1242–53. doi: 10.5858/arpa.2018-0901-SA Bernard V Kim DU San Lucas FA Castillo J Allenson K Mulu FC . Circulating nucleic acids are associated with outcomes of patients with pancreatic cancer. Gastroenterology (2019) 156(1):10818.e4. doi: 10.1053/j.gastro.2018.09.022 Marcuello M Vymetalkova V Neves RPL Duran-Sanchon S Vedeld HM Tham E . Circulating biomarkers for early detection and clinical management of colorectal cancer. Mol Aspects Med (2019) 69:107–22. doi: 10.1016/j.mam.2019.06.002 Chu D Paoletti C Gersch C VanDenBerg DA Zabransky DJ Cochran RL . ESR1 mutations in circulating plasma tumor DNA from metastatic breast cancer patients. Clin Cancer Res (2016) 22(4):993–9. doi: 10.1158/1078-0432.Ccr-15-0943 Angus L Beije N Jager A Martens JW Sleijfer S . ESR1 mutations: Moving towards guiding treatment decision-making in metastatic breast cancer patients. Cancer Treat Rev (2017) 52:3340. doi: 10.1016/j.ctrv.2016.11.001 Ma F Guan YF Yi ZB Chang LP Li Q Chen SS . Assessing tumor heterogeneity using ctDNA to predict and monitor therapeutic response in metastatic breast cancer. Int J Cancer (2020) 146(5):1359–68. doi: 10.1002/ijc.32536 Cullinane C Fleming C O'Leary DP Hassan F Kelly L O'Sullivan MJ . Association of circulating tumor DNA with disease-free survival in breast cancer a systematic review and meta-analysis. JAMA Network Open (2020) 3(11):e2026921. doi: 10.1001/jamanetworkopen.2020.26921 Tellez-Gabriel M Knutsen E Perander M . Current status of circulating tumor cells, circulating tumor DNA, and exosomes in breast cancer liquid biopsies. Int J Mol Sci (2020) 21(24):9457. doi: 10.3390/ijms21249457 Keller L Werner S Pantel K . Biology and clinical relevance of EpCAM. Cell Stress (2019) 3(6):165–80. doi: 10.15698/cst2019.06.188 Johansson G Andersson D Filges S Li J Muth A Godfrey TE . Considerations and quality controls when analyzing cell-free tumor DNA. Biomol detection quantification (2019) 17:100078. doi: 10.1016/j.bdq.2018.12.003 Ye Z Wang C Wan S Mu Z Zhang Z Abu-Khalaf MM . Association of clinical outcomes in metastatic breast cancer patients with circulating tumour cell and circulating cell-free DNA. Eur J Cancer (Oxford Engl 1990) (2019) 106:133–43. doi: 10.1016/j.ejca.2018.10.012 Schiavon G Hrebien S Garcia-Murillas I Cutts RJ Pearson A Tarazona N . Analysis of ESR1 mutation in circulating tumor DNA demonstrates evolution during therapy for metastatic breast cancer. Sci Trans Med (2015) 7(313):313ra182. doi: 10.1126/scitranslmed.aac7551 Guttery DS Page K Hills A Woodley L Marchese SD Rghebi B . Noninvasive detection of activating estrogen receptor 1 (ESR1) mutations in estrogen receptor-positive metastatic breast cancer. Clin Chem (2015) 61(7):974–82. doi: 10.1373/clinchem.2015.238717 Darrigues L Pierga JY Bernard-Tessier A Bieche I Silveira AB Michel M . Circulating tumor DNA as a dynamic biomarker of response to palbociclib and fulvestrant in metastatic breast cancer patients. Breast Cancer Res (2021) 23(1):31. doi: 10.1186/s13058-021-01411-0 Formisano L Lu Y Servetto A Hanker AB Jansen VM Bauer JA . Aberrant FGFR signaling mediates resistance to CDK4/6 inhibitors in ER plus breast cancer. Nat Commun (2019) 10(1):1373. doi: 10.1038/s41467-019-09068-2 Magbanua MJM Swigart LB Wu HT Hirst GL Yau C Wolf DM . Circulating tumor DNA in neoadjuvant-treated breast cancer reflects response and survival. Ann Oncol (2021) 32(2):229–39. doi: 10.1016/j.annonc.2020.11.007 Radovich M Jiang GL Hancock BA Chitambar C Nanda R Falkson C . Association of circulating tumor DNA and circulating tumor cells after neoadjuvant chemotherapy with disease recurrence in patients with triple-negative breast cancer preplanned secondary analysis of the BRE12-158 randomized clinical trial. JAMA Oncol (2020) 6(9):1410–5. doi: 10.1001/jamaoncol.2020.2295 Berger F Marce M Delaloge S Hardy-Bessard AC Bachelot T Bièche I . Randomised, open-label, multicentric phase III trial to evaluate the safety and efficacy of palbociclib in combination with endocrine therapy, guided by ESR1 mutation monitoring in oestrogen receptor-positive, HER2-negative metastatic breast cancer patients: study design of PADA-1. BMJ Open (2022) 12(3):e055821. doi: 10.1136/bmjopen-2021-055821 Cristofanilli M Turner NC Bondarenko I Ro J Im SA Masuda N . Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial. Lancet Oncol (2016) 17(4):425–39. doi: 10.1016/s1470-2045(15)00613-0 Cristofanilli M Rugo HS Im SA Slamon DJ Harbeck N Bondarenko I . Overall survival with palbociclib and fulvestrant in women with HR+/HER2- ABC: Updated exploratory analyses of PALOMA-3, a double-blind, phase III randomized study. Clin Cancer Res (2022) 28(16):3433–42. doi: 10.1158/1078-0432.Ccr-22-0305 Glossary
      BC breast cancer
      ctDNA crculating tumor DNA
      CGP cancer genome project
      NGS next-generation sequencing
      CRC colorectal cancer
      HCC hepatocellular carcinoma
      Mesh Medical Subject Headings
      WoS Web of Science
      SCI-EXPANDED Science Citation Index Expanded
      SSCI Social Sciences Citation Index
      ESCI Arts & Humanities Citation Index
      CCR-EXPANDED Current Chemical Reactions
      IC Index Chemicus
      h-index Hirsch index
      Tam-Seq tagged-amplicon deep sequencing
      MBC metastatic breast cancer
      ESR1 estrogen receptor alpha gene
      cfDNA cell-free DNA
      KRAS kirsten rat sarcoma viral oncogene
      AI aromatase inhibitors
      pCR pathological complete response
      ‘Oh, my dear Thomas, you haven’t heard the terrible news then?’ she said. ‘I thought you would be sure to have seen it placarded somewhere. Alice went straight to her room, and I haven’t seen her since, though I repeatedly knocked at the door, which she has locked on the inside, and I’m sure it’s most unnatural of her not to let her own mother comfort her. It all happened in a moment: I have always said those great motor-cars shouldn’t be allowed to career about the streets, especially when they are all paved with cobbles as they are at Easton Haven, which are{331} so slippery when it’s wet. He slipped, and it went over him in a moment.’ My thanks were few and awkward, for there still hung to the missive a basting thread, and it was as warm as a nestling bird. I bent low--everybody was emotional in those days--kissed the fragrant thing, thrust it into my bosom, and blushed worse than Camille. "What, the Corner House victim? Is that really a fact?" "My dear child, I don't look upon it in that light at all. The child gave our picturesque friend a certain distinction--'My husband is dead, and this is my only child,' and all that sort of thing. It pays in society." leave them on the steps of a foundling asylum in order to insure [See larger version] Interoffice guff says you're planning definite moves on your own, J. O., and against some opposition. Is the Colonel so poor or so grasping—or what? Albert could not speak, for he felt as if his brains and teeth were rattling about inside his head. The rest of[Pg 188] the family hunched together by the door, the boys gaping idiotically, the girls in tears. "Now you're married." The host was called in, and unlocked a drawer in which they were deposited. The galleyman, with visible reluctance, arrayed himself in the garments, and he was observed to shudder more than once during the investiture of the dead man's apparel. HoME香京julia种子在线播放 ENTER NUMBET 0016www.hnjnsbm.org.cn
      www.hiyacar.com.cn
      hisike.com.cn
      laowuu.com.cn
      j5lv9.com.cn
      gdesigner.com.cn
      www.jipbcd.com.cn
      rgec.com.cn
      orpxg7.com.cn
      shxunpu.com.cn
      处女被大鸡巴操 强奸乱伦小说图片 俄罗斯美女爱爱图 调教强奸学生 亚洲女的穴 夜来香图片大全 美女性强奸电影 手机版色中阁 男性人体艺术素描图 16p成人 欧美性爱360 电影区 亚洲电影 欧美电影 经典三级 偷拍自拍 动漫电影 乱伦电影 变态另类 全部电 类似狠狠鲁的网站 黑吊操白逼图片 韩国黄片种子下载 操逼逼逼逼逼 人妻 小说 p 偷拍10幼女自慰 极品淫水很多 黄色做i爱 日本女人人体电影快播看 大福国小 我爱肏屄美女 mmcrwcom 欧美多人性交图片 肥臀乱伦老头舔阴帝 d09a4343000019c5 西欧人体艺术b xxoo激情短片 未成年人的 插泰国人夭图片 第770弾み1 24p 日本美女性 交动态 eee色播 yantasythunder 操无毛少女屄 亚洲图片你懂的女人 鸡巴插姨娘 特级黄 色大片播 左耳影音先锋 冢本友希全集 日本人体艺术绿色 我爱被舔逼 内射 幼 美阴图 喷水妹子高潮迭起 和后妈 操逼 美女吞鸡巴 鸭个自慰 中国女裸名单 操逼肥臀出水换妻 色站裸体义术 中国行上的漏毛美女叫什么 亚洲妹性交图 欧美美女人裸体人艺照 成人色妹妹直播 WWW_JXCT_COM r日本女人性淫乱 大胆人艺体艺图片 女同接吻av 碰碰哥免费自拍打炮 艳舞写真duppid1 88电影街拍视频 日本自拍做爱qvod 实拍美女性爱组图 少女高清av 浙江真实乱伦迅雷 台湾luanlunxiaoshuo 洛克王国宠物排行榜 皇瑟电影yy频道大全 红孩儿连连看 阴毛摄影 大胆美女写真人体艺术摄影 和风骚三个媳妇在家做爱 性爱办公室高清 18p2p木耳 大波撸影音 大鸡巴插嫩穴小说 一剧不超两个黑人 阿姨诱惑我快播 幼香阁千叶县小学生 少女妇女被狗强奸 曰人体妹妹 十二岁性感幼女 超级乱伦qvod 97爱蜜桃ccc336 日本淫妇阴液 av海量资源999 凤凰影视成仁 辰溪四中艳照门照片 先锋模特裸体展示影片 成人片免费看 自拍百度云 肥白老妇女 女爱人体图片 妈妈一女穴 星野美夏 日本少女dachidu 妹子私处人体图片 yinmindahuitang 舔无毛逼影片快播 田莹疑的裸体照片 三级电影影音先锋02222 妻子被外国老头操 观月雏乃泥鳅 韩国成人偷拍自拍图片 强奸5一9岁幼女小说 汤姆影院av图片 妹妹人艺体图 美女大驱 和女友做爱图片自拍p 绫川まどか在线先锋 那么嫩的逼很少见了 小女孩做爱 处女好逼连连看图图 性感美女在家做爱 近距离抽插骚逼逼 黑屌肏金毛屄 日韩av美少女 看喝尿尿小姐日逼色色色网图片 欧美肛交新视频 美女吃逼逼 av30线上免费 伊人在线三级经典 新视觉影院t6090影院 最新淫色电影网址 天龙影院远古手机版 搞老太影院 插进美女的大屁股里 私人影院加盟费用 www258dd 求一部电影里面有一个二猛哥 深肛交 日本萌妹子人体艺术写真图片 插入屄眼 美女的木奶 中文字幕黄色网址影视先锋 九号女神裸 和骚人妻偷情 和潘晓婷做爱 国模大尺度蜜桃 欧美大逼50p 西西人体成人 李宗瑞继母做爱原图物处理 nianhuawang 男鸡巴的视屏 � 97免费色伦电影 好色网成人 大姨子先锋 淫荡巨乳美女教师妈妈 性nuexiaoshuo WWW36YYYCOM 长春继续给力进屋就操小女儿套干破内射对白淫荡 农夫激情社区 日韩无码bt 欧美美女手掰嫩穴图片 日本援交偷拍自拍 入侵者日本在线播放 亚洲白虎偷拍自拍 常州高见泽日屄 寂寞少妇自卫视频 人体露逼图片 多毛外国老太 变态乱轮手机在线 淫荡妈妈和儿子操逼 伦理片大奶少女 看片神器最新登入地址sqvheqi345com账号群 麻美学姐无头 圣诞老人射小妞和强奸小妞动话片 亚洲AV女老师 先锋影音欧美成人资源 33344iucoom zV天堂电影网 宾馆美女打炮视频 色五月丁香五月magnet 嫂子淫乱小说 张歆艺的老公 吃奶男人视频在线播放 欧美色图男女乱伦 avtt2014ccvom 性插色欲香影院 青青草撸死你青青草 99热久久第一时间 激情套图卡通动漫 幼女裸聊做爱口交 日本女人被强奸乱伦 草榴社区快播 2kkk正在播放兽骑 啊不要人家小穴都湿了 www猎奇影视 A片www245vvcomwwwchnrwhmhzcn 搜索宜春院av wwwsee78co 逼奶鸡巴插 好吊日AV在线视频19gancom 熟女伦乱图片小说 日本免费av无码片在线开苞 鲁大妈撸到爆 裸聊官网 德国熟女xxx 新不夜城论坛首页手机 女虐男网址 男女做爱视频华为网盘 激情午夜天亚洲色图 内裤哥mangent 吉沢明歩制服丝袜WWWHHH710COM 屌逼在线试看 人体艺体阿娇艳照 推荐一个可以免费看片的网站如果被QQ拦截请复制链接在其它浏览器打开xxxyyy5comintr2a2cb551573a2b2e 欧美360精品粉红鲍鱼 教师调教第一页 聚美屋精品图 中韩淫乱群交 俄罗斯撸撸片 把鸡巴插进小姨子的阴道 干干AV成人网 aolasoohpnbcn www84ytom 高清大量潮喷www27dyycom 宝贝开心成人 freefronvideos人母 嫩穴成人网gggg29com 逼着舅妈给我口交肛交彩漫画 欧美色色aV88wwwgangguanscom 老太太操逼自拍视频 777亚洲手机在线播放 有没有夫妻3p小说 色列漫画淫女 午间色站导航 欧美成人处女色大图 童颜巨乳亚洲综合 桃色性欲草 色眯眯射逼 无码中文字幕塞外青楼这是一个 狂日美女老师人妻 爱碰网官网 亚洲图片雅蠛蝶 快播35怎么搜片 2000XXXX电影 新谷露性家庭影院 深深候dvd播放 幼齿用英语怎么说 不雅伦理无需播放器 国外淫荡图片 国外网站幼幼嫩网址 成年人就去色色视频快播 我鲁日日鲁老老老我爱 caoshaonvbi 人体艺术avav 性感性色导航 韩国黄色哥来嫖网站 成人网站美逼 淫荡熟妇自拍 欧美色惰图片 北京空姐透明照 狼堡免费av视频 www776eom 亚洲无码av欧美天堂网男人天堂 欧美激情爆操 a片kk266co 色尼姑成人极速在线视频 国语家庭系列 蒋雯雯 越南伦理 色CC伦理影院手机版 99jbbcom 大鸡巴舅妈 国产偷拍自拍淫荡对话视频 少妇春梦射精 开心激动网 自拍偷牌成人 色桃隐 撸狗网性交视频 淫荡的三位老师 伦理电影wwwqiuxia6commqiuxia6com 怡春院分站 丝袜超短裙露脸迅雷下载 色制服电影院 97超碰好吊色男人 yy6080理论在线宅男日韩福利大全 大嫂丝袜 500人群交手机在线 5sav 偷拍熟女吧 口述我和妹妹的欲望 50p电脑版 wwwavtttcon 3p3com 伦理无码片在线看 欧美成人电影图片岛国性爱伦理电影 先锋影音AV成人欧美 我爱好色 淫电影网 WWW19MMCOM 玛丽罗斯3d同人动画h在线看 动漫女孩裸体 超级丝袜美腿乱伦 1919gogo欣赏 大色逼淫色 www就是撸 激情文学网好骚 A级黄片免费 xedd5com 国内的b是黑的 快播美国成年人片黄 av高跟丝袜视频 上原保奈美巨乳女教师在线观看 校园春色都市激情fefegancom 偷窥自拍XXOO 搜索看马操美女 人本女优视频 日日吧淫淫 人妻巨乳影院 美国女子性爱学校 大肥屁股重口味 啪啪啪啊啊啊不要 操碰 japanfreevideoshome国产 亚州淫荡老熟女人体 伦奸毛片免费在线看 天天影视se 樱桃做爱视频 亚卅av在线视频 x奸小说下载 亚洲色图图片在线 217av天堂网 东方在线撸撸-百度 幼幼丝袜集 灰姑娘的姐姐 青青草在线视频观看对华 86papa路con 亚洲1AV 综合图片2区亚洲 美国美女大逼电影 010插插av成人网站 www色comwww821kxwcom 播乐子成人网免费视频在线观看 大炮撸在线影院 ,www4KkKcom 野花鲁最近30部 wwwCC213wapwww2233ww2download 三客优最新地址 母亲让儿子爽的无码视频 全国黄色片子 欧美色图美国十次 超碰在线直播 性感妖娆操 亚洲肉感熟女色图 a片A毛片管看视频 8vaa褋芯屑 333kk 川岛和津实视频 在线母子乱伦对白 妹妹肥逼五月 亚洲美女自拍 老婆在我面前小说 韩国空姐堪比情趣内衣 干小姐综合 淫妻色五月 添骚穴 WM62COM 23456影视播放器 成人午夜剧场 尼姑福利网 AV区亚洲AV欧美AV512qucomwwwc5508com 经典欧美骚妇 震动棒露出 日韩丝袜美臀巨乳在线 av无限吧看 就去干少妇 色艺无间正面是哪集 校园春色我和老师做爱 漫画夜色 天海丽白色吊带 黄色淫荡性虐小说 午夜高清播放器 文20岁女性荫道口图片 热国产热无码热有码 2015小明发布看看算你色 百度云播影视 美女肏屄屄乱轮小说 家族舔阴AV影片 邪恶在线av有码 父女之交 关于处女破处的三级片 极品护士91在线 欧美虐待女人视频的网站 享受老太太的丝袜 aaazhibuo 8dfvodcom成人 真实自拍足交 群交男女猛插逼 妓女爱爱动态 lin35com是什么网站 abp159 亚洲色图偷拍自拍乱伦熟女抠逼自慰 朝国三级篇 淫三国幻想 免费的av小电影网站 日本阿v视频免费按摩师 av750c0m 黄色片操一下 巨乳少女车震在线观看 操逼 免费 囗述情感一乱伦岳母和女婿 WWW_FAMITSU_COM 偷拍中国少妇在公车被操视频 花也真衣论理电影 大鸡鸡插p洞 新片欧美十八岁美少 进击的巨人神thunderftp 西方美女15p 深圳哪里易找到老女人玩视频 在线成人有声小说 365rrr 女尿图片 我和淫荡的小姨做爱 � 做爱技术体照 淫妇性爱 大学生私拍b 第四射狠狠射小说 色中色成人av社区 和小姨子乱伦肛交 wwwppp62com 俄罗斯巨乳人体艺术 骚逼阿娇 汤芳人体图片大胆 大胆人体艺术bb私处 性感大胸骚货 哪个网站幼女的片多 日本美女本子把 色 五月天 婷婷 快播 美女 美穴艺术 色百合电影导航 大鸡巴用力 孙悟空操美少女战士 狠狠撸美女手掰穴图片 古代女子与兽类交 沙耶香套图 激情成人网区 暴风影音av播放 动漫女孩怎么插第3个 mmmpp44 黑木麻衣无码ed2k 淫荡学姐少妇 乱伦操少女屄 高中性爱故事 骚妹妹爱爱图网 韩国模特剪长发 大鸡巴把我逼日了 中国张柏芝做爱片中国张柏芝做爱片中国张柏芝做爱片中国张柏芝做爱片中国张柏芝做爱片 大胆女人下体艺术图片 789sss 影音先锋在线国内情侣野外性事自拍普通话对白 群撸图库 闪现君打阿乐 ady 小说 插入表妹嫩穴小说 推荐成人资源 网络播放器 成人台 149大胆人体艺术 大屌图片 骚美女成人av 春暖花开春色性吧 女亭婷五月 我上了同桌的姐姐 恋夜秀场主播自慰视频 yzppp 屄茎 操屄女图 美女鲍鱼大特写 淫乱的日本人妻山口玲子 偷拍射精图 性感美女人体艺木图片 种马小说完本 免费电影院 骑士福利导航导航网站 骚老婆足交 国产性爱一级电影 欧美免费成人花花性都 欧美大肥妞性爱视频 家庭乱伦网站快播 偷拍自拍国产毛片 金发美女也用大吊来开包 缔D杏那 yentiyishu人体艺术ytys WWWUUKKMCOM 女人露奶 � 苍井空露逼 老荡妇高跟丝袜足交 偷偷和女友的朋友做爱迅雷 做爱七十二尺 朱丹人体合成 麻腾由纪妃 帅哥撸播种子图 鸡巴插逼动态图片 羙国十次啦中文 WWW137AVCOM 神斗片欧美版华语 有气质女人人休艺术 由美老师放屁电影 欧美女人肉肏图片 白虎种子快播 国产自拍90后女孩 美女在床上疯狂嫩b 饭岛爱最后之作 幼幼强奸摸奶 色97成人动漫 两性性爱打鸡巴插逼 新视觉影院4080青苹果影院 嗯好爽插死我了 阴口艺术照 李宗瑞电影qvod38 爆操舅母 亚洲色图七七影院 被大鸡巴操菊花 怡红院肿么了 成人极品影院删除 欧美性爱大图色图强奸乱 欧美女子与狗随便性交 苍井空的bt种子无码 熟女乱伦长篇小说 大色虫 兽交幼女影音先锋播放 44aad be0ca93900121f9b 先锋天耗ばさ无码 欧毛毛女三级黄色片图 干女人黑木耳照 日本美女少妇嫩逼人体艺术 sesechangchang 色屄屄网 久久撸app下载 色图色噜 美女鸡巴大奶 好吊日在线视频在线观看 透明丝袜脚偷拍自拍 中山怡红院菜单 wcwwwcom下载 骑嫂子 亚洲大色妣 成人故事365ahnet 丝袜家庭教mp4 幼交肛交 妹妹撸撸大妈 日本毛爽 caoprom超碰在email 关于中国古代偷窥的黄片 第一会所老熟女下载 wwwhuangsecome 狼人干综合新地址HD播放 变态儿子强奸乱伦图 强奸电影名字 2wwwer37com 日本毛片基地一亚洲AVmzddcxcn 暗黑圣经仙桃影院 37tpcocn 持月真由xfplay 好吊日在线视频三级网 我爱背入李丽珍 电影师傅床戏在线观看 96插妹妹sexsex88com 豪放家庭在线播放 桃花宝典极夜著豆瓜网 安卓系统播放神器 美美网丝袜诱惑 人人干全免费视频xulawyercn av无插件一本道 全国色五月 操逼电影小说网 good在线wwwyuyuelvcom www18avmmd 撸波波影视无插件 伊人幼女成人电影 会看射的图片 小明插看看 全裸美女扒开粉嫩b 国人自拍性交网站 萝莉白丝足交本子 七草ちとせ巨乳视频 摇摇晃晃的成人电影 兰桂坊成社人区小说www68kqcom 舔阴论坛 久撸客一撸客色国内外成人激情在线 明星门 欧美大胆嫩肉穴爽大片 www牛逼插 性吧星云 少妇性奴的屁眼 人体艺术大胆mscbaidu1imgcn 最新久久色色成人版 l女同在线 小泽玛利亚高潮图片搜索 女性裸b图 肛交bt种子 最热门有声小说 人间添春色 春色猜谜字 樱井莉亚钢管舞视频 小泽玛利亚直美6p 能用的h网 还能看的h网 bl动漫h网 开心五月激 东京热401 男色女色第四色酒色网 怎么下载黄色小说 黄色小说小栽 和谐图城 乐乐影院 色哥导航 特色导航 依依社区 爱窝窝在线 色狼谷成人 91porn 包要你射电影 色色3A丝袜 丝袜妹妹淫网 爱色导航(荐) 好男人激情影院 坏哥哥 第七色 色久久 人格分裂 急先锋 撸撸射中文网 第一会所综合社区 91影院老师机 东方成人激情 怼莪影院吹潮 老鸭窝伊人无码不卡无码一本道 av女柳晶电影 91天生爱风流作品 深爱激情小说私房婷婷网 擼奶av 567pao 里番3d一家人野外 上原在线电影 水岛津实透明丝袜 1314酒色 网旧网俺也去 0855影院 在线无码私人影院 搜索 国产自拍 神马dy888午夜伦理达达兔 农民工黄晓婷 日韩裸体黑丝御姐 屈臣氏的燕窝面膜怎么样つぼみ晶エリーの早漏チ○ポ强化合宿 老熟女人性视频 影音先锋 三上悠亚ol 妹妹影院福利片 hhhhhhhhsxo 午夜天堂热的国产 强奸剧场 全裸香蕉视频无码 亚欧伦理视频 秋霞为什么给封了 日本在线视频空天使 日韩成人aⅴ在线 日本日屌日屄导航视频 在线福利视频 日本推油无码av magnet 在线免费视频 樱井梨吮东 日本一本道在线无码DVD 日本性感诱惑美女做爱阴道流水视频 日本一级av 汤姆avtom在线视频 台湾佬中文娱乐线20 阿v播播下载 橙色影院 奴隶少女护士cg视频 汤姆在线影院无码 偷拍宾馆 业面紧急生级访问 色和尚有线 厕所偷拍一族 av女l 公交色狼优酷视频 裸体视频AV 人与兽肉肉网 董美香ol 花井美纱链接 magnet 西瓜影音 亚洲 自拍 日韩女优欧美激情偷拍自拍 亚洲成年人免费视频 荷兰免费成人电影 深喉呕吐XXⅩX 操石榴在线视频 天天色成人免费视频 314hu四虎 涩久免费视频在线观看 成人电影迅雷下载 能看见整个奶子的香蕉影院 水菜丽百度影音 gwaz079百度云 噜死你们资源站 主播走光视频合集迅雷下载 thumbzilla jappen 精品Av 古川伊织star598在线 假面女皇vip在线视频播放 国产自拍迷情校园 啪啪啪公寓漫画 日本阿AV 黄色手机电影 欧美在线Av影院 华裔电击女神91在线 亚洲欧美专区 1日本1000部免费视频 开放90后 波多野结衣 东方 影院av 页面升级紧急访问每天正常更新 4438Xchengeren 老炮色 a k福利电影 色欲影视色天天视频 高老庄aV 259LUXU-683 magnet 手机在线电影 国产区 欧美激情人人操网 国产 偷拍 直播 日韩 国内外激情在线视频网给 站长统计一本道人妻 光棍影院被封 紫竹铃取汁 ftp 狂插空姐嫩 xfplay 丈夫面前 穿靴子伪街 XXOO视频在线免费 大香蕉道久在线播放 电棒漏电嗨过头 充气娃能看下毛和洞吗 夫妻牲交 福利云点墦 yukun瑟妃 疯狂交换女友 国产自拍26页 腐女资源 百度云 日本DVD高清无码视频 偷拍,自拍AV伦理电影 A片小视频福利站。 大奶肥婆自拍偷拍图片 交配伊甸园 超碰在线视频自拍偷拍国产 小热巴91大神 rctd 045 类似于A片 超美大奶大学生美女直播被男友操 男友问 你的衣服怎么脱掉的 亚洲女与黑人群交视频一 在线黄涩 木内美保步兵番号 鸡巴插入欧美美女的b舒服 激情在线国产自拍日韩欧美 国语福利小视频在线观看 作爱小视颍 潮喷合集丝袜无码mp4 做爱的无码高清视频 牛牛精品 伊aⅤ在线观看 savk12 哥哥搞在线播放 在线电一本道影 一级谍片 250pp亚洲情艺中心,88 欧美一本道九色在线一 wwwseavbacom色av吧 cos美女在线 欧美17,18ⅹⅹⅹ视频 自拍嫩逼 小电影在线观看网站 筱田优 贼 水电工 5358x视频 日本69式视频有码 b雪福利导航 韩国女主播19tvclub在线 操逼清晰视频 丝袜美女国产视频网址导航 水菜丽颜射房间 台湾妹中文娱乐网 风吟岛视频 口交 伦理 日本熟妇色五十路免费视频 A级片互舔 川村真矢Av在线观看 亚洲日韩av 色和尚国产自拍 sea8 mp4 aV天堂2018手机在线 免费版国产偷拍a在线播放 狠狠 婷婷 丁香 小视频福利在线观看平台 思妍白衣小仙女被邻居强上 萝莉自拍有水 4484新视觉 永久发布页 977成人影视在线观看 小清新影院在线观 小鸟酱后丝后入百度云 旋风魅影四级 香蕉影院小黄片免费看 性爱直播磁力链接 小骚逼第一色影院 性交流的视频 小雪小视频bd 小视频TV禁看视频 迷奸AV在线看 nba直播 任你在干线 汤姆影院在线视频国产 624u在线播放 成人 一级a做爰片就在线看狐狸视频 小香蕉AV视频 www182、com 腿模简小育 学生做爱视频 秘密搜查官 快播 成人福利网午夜 一级黄色夫妻录像片 直接看的gav久久播放器 国产自拍400首页 sm老爹影院 谁知道隔壁老王网址在线 综合网 123西瓜影音 米奇丁香 人人澡人人漠大学生 色久悠 夜色视频你今天寂寞了吗? 菲菲影视城美国 被抄的影院 变态另类 欧美 成人 国产偷拍自拍在线小说 不用下载安装就能看的吃男人鸡巴视频 插屄视频 大贯杏里播放 wwwhhh50 233若菜奈央 伦理片天海翼秘密搜查官 大香蕉在线万色屋视频 那种漫画小说你懂的 祥仔电影合集一区 那里可以看澳门皇冠酒店a片 色自啪 亚洲aV电影天堂 谷露影院ar toupaizaixian sexbj。com 毕业生 zaixian mianfei 朝桐光视频 成人短视频在线直接观看 陈美霖 沈阳音乐学院 导航女 www26yjjcom 1大尺度视频 开平虐女视频 菅野雪松协和影视在线视频 华人play在线视频bbb 鸡吧操屄视频 多啪啪免费视频 悠草影院 金兰策划网 (969) 橘佑金短视频 国内一极刺激自拍片 日本制服番号大全magnet 成人动漫母系 电脑怎么清理内存 黄色福利1000 dy88午夜 偷拍中学生洗澡磁力链接 花椒相机福利美女视频 站长推荐磁力下载 mp4 三洞轮流插视频 玉兔miki热舞视频 夜生活小视频 爆乳人妖小视频 国内网红主播自拍福利迅雷下载 不用app的裸裸体美女操逼视频 变态SM影片在线观看 草溜影院元气吧 - 百度 - 百度 波推全套视频 国产双飞集合ftp 日本在线AV网 笔国毛片 神马影院女主播是我的邻居 影音资源 激情乱伦电影 799pao 亚洲第一色第一影院 av视频大香蕉 老梁故事汇希斯莱杰 水中人体磁力链接 下载 大香蕉黄片免费看 济南谭崔 避开屏蔽的岛a片 草破福利 要看大鸡巴操小骚逼的人的视频 黑丝少妇影音先锋 欧美巨乳熟女磁力链接 美国黄网站色大全 伦蕉在线久播 极品女厕沟 激情五月bd韩国电影 混血美女自摸和男友激情啪啪自拍诱人呻吟福利视频 人人摸人人妻做人人看 44kknn 娸娸原网 伊人欧美 恋夜影院视频列表安卓青青 57k影院 如果电话亭 avi 插爆骚女精品自拍 青青草在线免费视频1769TV 令人惹火的邻家美眉 影音先锋 真人妹子被捅动态图 男人女人做完爱视频15 表姐合租两人共处一室晚上她竟爬上了我的床 性爱教学视频 北条麻妃bd在线播放版 国产老师和师生 magnet wwwcctv1024 女神自慰 ftp 女同性恋做激情视频 欧美大胆露阴视频 欧美无码影视 好女色在线观看 后入肥臀18p 百度影视屏福利 厕所超碰视频 强奸mp magnet 欧美妹aⅴ免费线上看 2016年妞干网视频 5手机在线福利 超在线最视频 800av:cOm magnet 欧美性爱免播放器在线播放 91大款肥汤的性感美乳90后邻家美眉趴着窗台后入啪啪 秋霞日本毛片网站 cheng ren 在线视频 上原亚衣肛门无码解禁影音先锋 美脚家庭教师在线播放 尤酷伦理片 熟女性生活视频在线观看 欧美av在线播放喷潮 194avav 凤凰AV成人 - 百度 kbb9999 AV片AV在线AV无码 爱爱视频高清免费观看 黄色男女操b视频 观看 18AV清纯视频在线播放平台 成人性爱视频久久操 女性真人生殖系统双性人视频 下身插入b射精视频 明星潜规测视频 mp4 免賛a片直播绪 国内 自己 偷拍 在线 国内真实偷拍 手机在线 国产主播户外勾在线 三桥杏奈高清无码迅雷下载 2五福电影院凸凹频频 男主拿鱼打女主,高宝宝 色哥午夜影院 川村まや痴汉 草溜影院费全过程免费 淫小弟影院在线视频 laohantuiche 啪啪啪喷潮XXOO视频 青娱乐成人国产 蓝沢润 一本道 亚洲青涩中文欧美 神马影院线理论 米娅卡莉法的av 在线福利65535 欧美粉色在线 欧美性受群交视频1在线播放 极品喷奶熟妇在线播放 变态另类无码福利影院92 天津小姐被偷拍 磁力下载 台湾三级电髟全部 丝袜美腿偷拍自拍 偷拍女生性行为图 妻子的乱伦 白虎少妇 肏婶骚屄 外国大妈会阴照片 美少女操屄图片 妹妹自慰11p 操老熟女的b 361美女人体 360电影院樱桃 爱色妹妹亚洲色图 性交卖淫姿势高清图片一级 欧美一黑对二白 大色网无毛一线天 射小妹网站 寂寞穴 西西人体模特苍井空 操的大白逼吧 骚穴让我操 拉好友干女朋友3p